Cross-Sectional Survey of Written Medicine Information Use, Health Literacy and Adherence among Hypertensive Patients in Southwest Nigeria
DOI:
https://doi.org/10.51412/psnnjp.2025.02Keywords:
Hypertension, Written Medicine Information, Adherence, Behaviour, KnowledgeAbstract
Introduction: Hypertension is the leading risk factor for cardiovascular and kidney disease in Nigeria and significantly contributes to morbidity and mortality. In spite of available, safe and efficacious medicines, diagnosis, initiation of treatment, and treatment outcomes are still suboptimal in Nigeria. Only 29% are diagnosed, 12% are being treated and 2.8% at treatment goals. This study aimed to investigate how hypertensive patients in Southwest Nigeria use written medicine information (WMIs) and their impact on adherence to medicine use.
Methods: This was a cross-sectional survey among hypertensive patients living in Southwest Nigeria. The survey tool used was pre-validated (Cronbach alpha 0.774); it elicits demographic information and research questions on behaviour, experience, knowledge of medicine for hypertension and adherence. The population was systematically sampled (every X+1th patient) for qualified respondents. The data were summarised using descriptive statistics and analysed with a chi-square test for categorical outcomes. Microsoft Excel and SPSS v29 were used for the analysis of the data. The study was approved and given oversight by the Health and Research Ethics Committee of the Lagos University Teaching Hospital, Idi-Araba.
Results: Most of the respondents (72.6%) in the study reported having seen a WMI in the past three months, with a majority (61.7%) reporting that they opened it up to read it. Fewer respondents however identified that they always opened the WMI to read if they were getting the medicine for the first time (6.1%), had got it more than once (8.9%) or the WMI had been used in the counselling session (15.4%). Most of the respondents reported having a positive experience with WMIs. The relationship between patient's adherence score to age, their preferred information source, behaviours and impact (except for impact of WMIs on information seeking behaviour) was statistically significant (p< 0.05).
Conclusion: This study shows that across the four states, patient experience with WMIs was largely positive, though moderated by poor health literacy and inadequate adherence to medicines.
References
World Health Organization (2023) Hypertension: key facts. Cited 25th March 2023. Available https://www.who.int/news-room/fact-sheets/ detail/hypertension
Hamrahian SM, Maarouf OH, Fülöp T (2022) A Critical Review of Medication Adherence in Hypertension: Barriers and Facilitators Clinicians Should Consider. Patient Prefer Adherence. 16: 2749-2757. https://doi.org/10.2147/ppa.s368784
Adeloye D, Owolabi EO, Ojji DB, Auta A, Dewan MT, Olanrewaju TO, Ogah OS, Omoyele C, Ezeigwe N, Mpazanje RG, Gadanya MA, Agogo
E, Alemu W, Adebiyi AO, Harhay MO (2021). Prevalence, awareness, treatment, and control of hypertension in Nigeria in 1995 and 2020: A
systematic analysis of current evidence. Journal of Clinical Hypertension (Greenwich), 23(5):963-977. https://doi.org/10.1111/jch.14220
Mendis S and Salas M (2003) 'Hypertension' in, Sabate E (ed.) Adherence to Long term therapiesevidence for action. Switzerland: WHO pp. 107
Amadi CA, Adeyemi OC, Joda AE, Mbakwem AC, Ajuluchukwu JN (2014) Self-reported adherence to Antihypertensive drugs in a Nigerian
population using the Morisky Medication Adherence Scale. Nigerian Quarterly Journal of Hospital Medicine, 24 (2): 144-149.
Aminde LN, Agbor VN, Fongwen NT, Ngwasiri C, Nkoke C, Nji M, Dzudie A, Schutte AE (2024) High burden of non-adherence to blood pressurelowering medications: meta-analysis of data from over 34,000 adults with hypertension in SubSaharan Africa. medRxiv24308082; https://doi.org/10.1101/2024.05.28.24308082
Festing MF (2006) Design and statistical methods in studies using animal models of development. ILARJ47 (1): 5 – 14.
https://doi.org/10.1093/ilar.47.1.5
Herber OR, Gies V, Schwappach D, Thürmann P, & Wilm S (2014). Patient information leaflets: Informing or frightening? A focus group study exploring patients' emotional reactions. BMC Family Practice, 15: 163. https://doi.org/10.1186/1471-2296-15-163
The European Medicines Agency: Guideline on the Readability of the Labelling and Package Leaflet of Medicinal Products for Human Use. [Accessed 10 Feb 2025]. Available at: https://ec.europa.eu/health/system/files/2016-11/2009_01_12_readability_guideline_final_en_0.pdf
Grime J, Blenkinsopp A, Raynor DK, Pollock K, & Knapp P (2007) The role and value of written information for patients about individual
medicines: A systematic review. Health Expectations, 10(3), 286-298. https://doi.org/10.1111/j.13697625.2007.00454.x
Krska J, Morecroft CW (2013) Patients' use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical inpatients. Drug Safety , 36(8): 673-80. https://doi:10.1007/s40264-013-0065-3
Horne R, Weinman J, Barber N, Elliott R, & Morgan M (2013) Concordance, adherence, and compliance in medicine-taking. National Coordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO). https://www.ahpo.net/assets/NCCSDO%20Compliance%202005.pdf.Accessed January 22, 2025.
Raynor DK, Blenkinsopp A, Knapp P, Grime J, Nicolson DJ, Pollock K, & Dorer G (2007) A systematic review of quantitative and qualitative research on the role and effectiveness of written medicine information. Health Technology Assessment, 11(5), 1-160.
https://doi.org/10.3310/hta11050
James PA, Oparil S, Carter BL, et al. (2014) evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA, 311:507e20. https://doi.org/10.1001/jama.2013.284427
Mohamed S, Mohamed R, Wael G, Haitham H, Hala M, Awni G, Sameh A (2019) Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: A multicenter randomized clinical trial. Pregnancy Hypertension, 17: 54-58.
https://doi.org/10.1016/j.preghy.2019.05.009.
Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH, Cochrane Hypertension Group (2017). Beta-blockers for hypertension. Cochrane Database of Sysytematic Review, 1:CD002003. https://doi.org/10.1002/14651858.cd002003.pub5
Koster ES, Blom L, Philbert D, & Bouvy ML (2015). The influence of patient characteristics on reading and assessng written medicine
information. Patient Education and Counseling, 98(5): 527-534.
Nieuwlaat R, Wilczynski N, Navarro T et al. (2014) Interventions for enhancing medication adherence. Cochrane Database of Systematic
Reviews, 11: CD000011. https://doi.org/10.1002/14651858.cd000011.pub4
Brown MT, & Bussell JK (2011) Medicationad herence: WHO cares? Mayo Clinic Proceedings, 86 (4): 304–314.
https://doi.org/10.4065/mcp.2010.0575
Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008) Interventions for enhancing medication adherence. Cochrane
Database of Systematic Reviews, (2) CD00001. https://doi.org/10.1002/14651858.cd000011.pub3
Nguyen, Thi-My-Uyen, La Caze, Adam, and Cottrell, Neil (2014) What are validated selfreport adherence scales really measuring? a systematic review. British Journal of Clinical Pharmacology, 77(3): 427 - 445. https://doi.org/10.1111/bcp.12194
Nualdaisri P, Katusiime B, & Krska J (2024) Written medicine information: Global considerations. International Journal of Pharmacy Practice, 32 (6): 429 - 430. https://doi.org/10.1093/ijpp/riae063
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 The Nigerian Journal of Pharmacy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
